14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:PGNX
Delisted

Progenics Pharmaceuticals Inc. Stock Predictions

$4.10
+0 (+0%)
At Close: Sep 04, 2020
Currently predicting for Wed, 24 Apr 2024

PGNX Predictions History

3 years ago
tingies predicted that PGNX for 2020-05-29 is going

Rank:

3 years ago
Joseph.Harrison.118997 predicted that PGNX for 2020-05-29 is going

Rank:

3 years ago
coralli predicted that PGNX for 2020-05-29 is going $4.44 (1.83%)

4 years ago
GoldenNugget predicted that PGNX for 2019-05-07 is going $5.29 (-3.31%)

4 years ago
NameNotImportant predicted that PGNX for 2019-05-06 is going $5.40 (2.27%)

4 years ago
GoldenNugget predicted that PGNX for 2019-05-06 is going $5.05 (-4.39%)

4 years ago
NameNotImportant predicted that PGNX for 2019-05-03 is going $4.99 (-5.49%)

5 years ago
PumpTheseNumbers predicted that PGNX for 2019-03-26 is going $4.26 (-3.40%)

5 years ago
JS predicted that PGNX for 2019-03-26 is going $4.26 (-3.40%)

5 years ago
Brent.Coussou.83584 predicted that PGNX for 2019-03-26 is going $4.69 (9.32%)

Rank:
Click to get the best stock tips daily for free!

About Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals. Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include Azedra, a radiotherapeutic product candidate, which is in Phase IIb clinical trial under special protocol assessment for the treatment of pheochromocytoma and paraganglioma; 1404, a technetium-99m labeled small molecule that has completed Phase II testing, as well as acts as an ... PGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT